Class information for:
Level 1: FOLLICULAR LYMPHOMA//NON HODGKINS LYMPHOMA//AGGRESSIVE NON HODGKINS LYMPHOMA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
710 3073 33.9 73%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
39 32196 MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FOLLICULAR LYMPHOMA Author keyword 101 28% 10% 311
2 NON HODGKINS LYMPHOMA Author keyword 52 12% 13% 400
3 AGGRESSIVE NON HODGKINS LYMPHOMA Author keyword 26 61% 1% 28
4 FLIPI Author keyword 23 79% 0% 15
5 AGGRESSIVE LYMPHOMA Author keyword 19 43% 1% 34
6 AGGRESSIVE NHL Author keyword 17 72% 0% 13
7 TRANSFORMED LYMPHOMA Author keyword 15 77% 0% 10
8 MACOP B Author keyword 14 64% 0% 14
9 HIGH GRADE NHL Author keyword 12 75% 0% 9
10 DIFFUSE LARGE CELL LYMPHOMA Author keyword 12 31% 1% 31

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FOLLICULAR LYMPHOMA 101 28% 10% 311 Search FOLLICULAR+LYMPHOMA Search FOLLICULAR+LYMPHOMA
2 NON HODGKINS LYMPHOMA 52 12% 13% 400 Search NON+HODGKINS+LYMPHOMA Search NON+HODGKINS+LYMPHOMA
3 AGGRESSIVE NON HODGKINS LYMPHOMA 26 61% 1% 28 Search AGGRESSIVE+NON+HODGKINS+LYMPHOMA Search AGGRESSIVE+NON+HODGKINS+LYMPHOMA
4 FLIPI 23 79% 0% 15 Search FLIPI Search FLIPI
5 AGGRESSIVE LYMPHOMA 19 43% 1% 34 Search AGGRESSIVE+LYMPHOMA Search AGGRESSIVE+LYMPHOMA
6 AGGRESSIVE NHL 17 72% 0% 13 Search AGGRESSIVE+NHL Search AGGRESSIVE+NHL
7 TRANSFORMED LYMPHOMA 15 77% 0% 10 Search TRANSFORMED+LYMPHOMA Search TRANSFORMED+LYMPHOMA
8 MACOP B 14 64% 0% 14 Search MACOP+B Search MACOP+B
9 HIGH GRADE NHL 12 75% 0% 9 Search HIGH+GRADE+NHL Search HIGH+GRADE+NHL
10 DIFFUSE LARGE CELL LYMPHOMA 12 31% 1% 31 Search DIFFUSE+LARGE+CELL+LYMPHOMA Search DIFFUSE+LARGE+CELL+LYMPHOMA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTERMEDIATE GRADE 184 61% 6% 195
2 DIFFUSE HISTIOCYTIC LYMPHOMA 160 63% 5% 160
3 DETUDE DES LYMPHOMES 149 67% 4% 135
4 MACOP B 112 61% 4% 118
5 STANDARD REGIMEN CHOP 90 58% 3% 104
6 HIGH DOSE THERAPY 83 23% 10% 319
7 LOW GRADE LYMPHOMA 76 41% 5% 143
8 LARGE CELL LYMPHOMA 72 21% 10% 305
9 AGGRESSIVE LYMPHOMA 62 40% 4% 122
10 INTERNATIONAL PROGNOSTIC INDEX 62 39% 4% 124

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: A systematic review and meta-analysis 2007 172 35 54%
A Canadian Evidence-Based Guideline for the First-Line Treatment of Follicular Lymphoma: Joint Consensus of the Lymphoma Canada Scientific Advisory Board 2015 1 54 83%
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20(+) NHL: a prospective randomized HOVON trial 2008 83 18 83%
Follicular lymphoma: 2014 update on diagnosis and management 2014 8 104 68%
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis 2012 23 24 75%
How we manage follicular lymphoma 2014 7 87 60%
Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials 2009 77 21 38%
Follicular lymphoma: 2012 update on diagnosis and management 2012 21 95 62%
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma 2015 1 107 42%
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review 2011 19 73 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 OSPED EMATOL 4 56% 0.2% 5
2 HEMATOL SECT 2 3 60% 0.1% 3
3 SC EMATOL 2 3 60% 0.1% 3
4 HEMATOL F4 224 2 67% 0.1% 2
5 LYMPHOMA COMM 2 67% 0.1% 2
6 MED 987680 2 67% 0.1% 2
7 MODENA CANC 2 67% 0.1% 2
8 UNIV DIST HOSP 2 67% 0.1% 2
9 UO SEMPLICE ONCOEMATOL 2 67% 0.1% 2
10 DIENST HEMATOL 2 50% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000159003 CD20//OFATUMUMAB//OBINUTUZUMAB
2 0.0000148849 DIFFUSE LARGE B CELL LYMPHOMA//PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA//GRAY ZONE LYMPHOMA
3 0.0000122152 FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA
4 0.0000121878 BENDAMUSTINE//TREANDA//BENDAMUSTIN
5 0.0000111986 PROLIFERATING CELL NUCLEAR ANTIGEN CYCLIN//BRASILENSE//IMMUNE MEDIATED THROMBOCYTOPENIC PURPURA
6 0.0000104596 INTERIM PET//INTERIM PET CT//PET IMAGING ST THOMAS
7 0.0000087667 MANTLE CELL LYMPHOMA//T1114//BCL 1
8 0.0000084506 HODGKINS DISEASE//HODGKIN LYMPHOMA//HODGKINS LYMPHOMA
9 0.0000082401 WALDEYERS RING//LARYNGEAL LYMPHOMA//TONSILLAR LYMPHOMA
10 0.0000080565 RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN